MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2025 Marie-Josée Kravis Women ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and ...

MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Tea will be served at 1:15 p.m., immediately preceding the seminar. Monday, March 31, 2025 - 1:30 p.m. to 2:30 p.m.

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Esta información le ayudará a prepararse para salir del hospital después de su terapia con células efectoras inmunitarias (IEC). A medida que lea esta información, anote cualquier pregunta que tenga p ...

This seminar is open to the research community.

This seminar is open to the research community.